EOLS

시간 외 거래: 4.93 -0.02 -0.40%

Evolus Inc (EOLS)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Relative Volume:

Evolus Inc Stock (EOLS) Company Profile

Healthcare (1113)

(949) 284-4555

520 NEWPORT CENTER DRIVE, NEWPORT BEACH

@evolusaesthetic

최신 SEC 제출 서류

EOLS's Discussions on Twitter

EOLS을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
EOLS Evolus Inc	4.95	312.43M	202.09M	-61.69M	-35.64M	-1.08
ZTS Zoetis Inc	124.96	54.61B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	16.91	52.47B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	10.42	46.18B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	32.53	36.87B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	476.78	20.38B	3.08B	1.24B	1.07B	25.61

Evolus Inc Stock (EOLS) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-08-06	다운그레이드	Needham	Buy → Hold
2025-04-17	개시	BTIG Research	Buy
2024-01-29	업그레이드	Barclays	Equal Weight → Overweight
2022-06-23	개시	Needham	Buy
2022-05-12	업그레이드	Barclays	Underweight → Equal Weight
2022-01-20	업그레이드	Truist	Hold → Buy
2021-05-06	업그레이드	Mizuho	Neutral → Buy
2021-04-08	재확인	H.C. Wainwright	Buy
2021-02-24	다운그레이드	Truist	Buy → Hold
2020-07-07	다운그레이드	Mizuho	Buy → Neutral
2020-02-06	재개	Mizuho	Buy
2019-11-26	개시	SVB Leerink	Outperform
2019-09-05	재개	Mizuho	Buy
2019-06-28	개시	Wells Fargo	Market Perform
2019-06-11	개시	Barclays	Underweight
2019-03-20	개시	SunTrust	Buy
2019-02-14	개시	H.C. Wainwright	Buy
2019-01-29	개시	Stifel	Buy

Evolus Inc 주식(EOLS)의 최신 뉴스

Evolus Inc (EOLS) 재무 분석

Evolus Inc (EOLS)

Evolus Inc Stock (EOLS) Company Profile

EOLS을(를) 다른 주식과 비교

Evolus Inc Stock (EOLS) Upgrades & Downgrades

Evolus Inc 주식(EOLS)의 최신 뉴스

How A New Price Target Is Shaping The Evolus (EOLS) Story - Yahoo Finance

Evolus (NASDAQ:EOLS) Given New $13.00 Price Target at BTIG Research - MarketBeat

EOLS: BTIG Lowers Price Target While Maintaining Buy Rating | EO - GuruFocus

Understanding Momentum Shifts in (EOLS) - Stock Traders Daily

BTIG lowers Evolus stock price target to $13 on aesthetic market decline - Investing.com Nigeria

Evolus projects robust 2025 growth with upcoming product launches - MSN

Panic Selling: Should you avoid Evolus Inc stock right nowEarnings Performance Report & Capital Efficient Trade Techniques - baoquankhu1.vn

Lacklustre Performance Is Driving Evolus, Inc.'s (NASDAQ:EOLS) 30% Price Drop - 富途牛牛

VIX Spike: Is Evolus Inc undervalued by DCF analysis2025 Market WrapUp & Safe Entry Trade Reports - baoquankhu1.vn

Stifel Analyst Lowers Price Target on Evolus (EOLS) to $17.00 | - GuruFocus

Stifel lowers Evolus stock price target to $17 on tempered growth outlook - Investing.com Australia

Stifel lowers Evolus stock price target to $17 on tempered growth outlook By Investing.com - Investing.com South Africa

Evolus, Inc. (NASDAQ:EOLS) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Avoiding Lag: Real-Time Signals in (EOLS) Movement - Stock Traders Daily

Evolus reports 15% Q4 growth, projects 2026 profitability By Investing.com - Investing.com Nigeria

Evolus sees FY26 revenue $327M-$337M, consensus $351.66M - TipRanks

Evolus sees Q4 revenue $88.6M-$90.6M, consensus $90.91M - TipRanks

Evolus, Inc. (EOLS) Stock Analysis: Unpacking a 222% Potential Upside in the Aesthetic Market - DirectorsTalk Interviews

EOLS: HC Wainwright & Co. Reiterates Buy Rating with $20 Price T - GuruFocus

Evolus' (EOLS) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Evolus (EOLS) Projects Strong Revenue Growth Through 2028 - GuruFocus

EOLS Projects Strong Revenue Growth with Key Product Line - GuruFocus

Evolus (EOLS) Achieves Sixth Year of Double-Digit Growth in 2025 - GuruFocus

EOLS Projects Optimistic Growth with Strategic Market Expansion - GuruFocus

Evolus outlook FY sales USD 327-337 million - marketscreener.com

Evolus reports 15% Q4 growth, projects 2026 profitability - Investing.com

Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue - Business Wire

How Evolus Inc. stock valuations compare to rivalsMarket Growth Review & Stock Timing and Entry Methods - Улправда

Does Evolus Inc. stock trade at a discount to peersChart Signals & Reliable Breakout Forecasts - Улправда

Why Evolus Inc. stock is favored by top institutions2025 Performance Recap & Expert Curated Trade Setup Alerts - Улправда

Can Evolus Inc. stock deliver strong Q4 earningsSwing Trading Ideas & Small Budget Portfolio Growth - Улправда

Insider Sellers Might Regret Selling Evolus Shares at a Lower Price Than Current Market Value - simplywall.st

Mizuho cuts Evolus (EOLS) estimates for Jeuveau/Evolysse on waning consumer sentiment and inflationary pressure on elective aesthetics - MSN

Will Evolus Inc. (EVL) stock benefit from sector leadershipRisk Mitigation Techniques & Low Entry Cost Investments - ulpravda.ru

Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR) and Evolus (EOLS) - The Globe and Mail

Discipline and Rules-Based Execution in EOLS Response - Stock Traders Daily

Avelar Rui, Evolus officer, sells $16k in EOLS stock By Investing.com - Investing.com India

Evolus CEO Moatazedi sells $75k in shares By Investing.com - Investing.com Australia

Evolus CEO Moatazedi sells $75k in shares - Investing.com

Avelar Rui, Evolus officer, sells $16k in EOLS stock - Investing.com

Insider Selling: Evolus (NASDAQ:EOLS) Insider Sells 10,539 Shares of Stock - MarketBeat

Rui Avelar Sells 2,261 Shares of Evolus (NASDAQ:EOLS) Stock - MarketBeat

ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away - The Motley Fool

Evolus, Inc. $EOLS Shares Acquired by Rice Hall James & Associates LLC - MarketBeat

Big Picture: Does Evolus Inc stock trade at a discount to peersPortfolio Update Summary & AI Powered Buy and Sell Recommendations - moha.gov.vn

Evolus' (EOLS) "Hold" Rating Reaffirmed at Needham & Company LLC - MarketBeat

Needham Reiterates Evolus (EOLS) Hold Recommendation - Nasdaq

Evolus Inc (EOLS) 재무 분석

매출

순이익

현금흐름

주당 순 이익

EOLS과 유사한 종목